The Power of Technology in Bioengineering Technology plays a critical role in the success of bioengineering, an ever-evolving field in which scientists spend their time researching new ways to improve biology by leveraging principles of engineering. In some instances, bioengineering efforts can be lifesaving. This includes improving current medical procedures and propelling pharmaceutical research. But […]
The modern laboratory can be a complicated environment. Laboratories are filled with highly specialized and expensive pieces of equipment. Researchers perform workflows and processes that not only have many different steps but must also be performed with a high degree of precision to guarantee accurate results. Naturally, before automating such a complex environment, it is […]
Imagine a lab environment where automation generates raw data, processes it, and outputs exactly what you need so that you can focus your efforts on science. The system can actually make decisions in real-time and continuously refine experiments. Today, the inherent complexity in these types of systems can be streamlined and software can come to the rescue, freeing the scientist from mundane repetitive tasks. Simplifying the laboratory experience has been a goal for TetraScience and HighRes Biosolutions, and the latest […]
Integration between HighRes Biosolutions’ Cellario lab automation software and the TetraScience Platform provides cloud-based data management and unlocks data science Authors: Kai Wang, Delivery Team Lead, TetraScience Spin Wang, CEO and Co-Founder, TetraScience Ira Hoffman, CEO, HighRes Biosolutions HighRes Biosolutions Cellario lab automation system with the TetraScience Data Integration Platform to optimize data management […]
It’s that time of year when your leadership team will start performing 2020 budget planning. You may be considering a liquid handler for your team or you may be thinking bigger and want a robotic solution. Whichever solution is the best fit for you, we suggest you consider all aspects as you do not want […]
Yesterday, Recursion Pharmaceuticals announced that the Food and Drug Administration had cleared their investigational new drug application for a Phase 1 clinical trial in the treatment of cerebral cavernous malformation (CCM). While this is certainly good news for treating this rare genetic disease, it is also an important milestone in the use of machine learning […]
